1-230178261-A-G
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_004481.5(GALNT2):c.170A>G(p.His57Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004481.5 missense
Scores
Clinical Significance
Conservation
Publications
- congenital disorder of glycosylation, type iitInheritance: AR Classification: STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALNT2 | NM_004481.5 | c.170A>G | p.His57Arg | missense_variant | Exon 2 of 16 | ENST00000366672.5 | NP_004472.1 | |
GALNT2 | NM_001291866.2 | c.56A>G | p.His19Arg | missense_variant | Exon 2 of 16 | NP_001278795.1 | ||
GALNT2 | XM_017000964.3 | c.77A>G | p.His26Arg | missense_variant | Exon 3 of 17 | XP_016856453.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000756 AC: 19AN: 251408 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461814Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727218 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74372 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.170A>G (p.H57R) alteration is located in exon 2 (coding exon 2) of the GALNT2 gene. This alteration results from a A to G substitution at nucleotide position 170, causing the histidine (H) at amino acid position 57 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at